About The Study: Individuals receiving methadone had a lower risk of treatment discontinuation compared with those who received buprenorphine/naloxone. The risk of mortality while receiving ...

Maintenance phase: use buprenorphine/naloxone sublingual films at the same buprenorphine dose as Day 2; if intolerant to naloxone, may adjust buprenorphine by 2mg or 4mg increments/decrements to ...

Two of the most effective medications for opioid use disorder are Suboxone (buprenorphine/naloxone) and methadone. While both ...

It is a combination drug that contains two active ingredients: buprenorphine and naloxone. Buprenorphine is a partial opioid ...

Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study published online Oct.

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone. The new ...

This paper included more than 30,000 patients with OUD and showed those on methadone were almost 60% significantly less ...

Opens in a new tab or window Patients with opioid use disorder (OUD) had a lower risk of discontinuing methadone compared with buprenorphine/naloxone, and with a similar mortality risk ...

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone. The new ...

Methadone showed lower treatment discontinuation risk than buprenorphine/naloxone in OUD patients, with longer median treatment duration. Current international guidelines for opioid agonist ...

The study, published in the Journal of the American Medical Association last week, used anonymous health data of nearly every patient prescribed either methadone or buprenorphine/naloxone, often sold ...

The study, published in the Journal of the American Medical Association last week, used anonymous health data of nearly every patient prescribed either methadone or buprenorphine/naloxone ...